요양병원의 항생제 현황 분석 및 평가지표 개발
- Type
- Research report
- Issued Date
- 2025-01
- Publisher
- 건강보험심사평가원
- Table Of Contents
- 요약 ···························································································· ⅰ
제1장 서론
1. 연구 배경 및 목적 ················································································ 3
2. 연구 내용 및 방법 ·················································································· 7
제2장 국내외 요양병원 항생제 관리 현황
1. 국내 ···································································································· 11
가. 요양병원 수가 및 환자평가표 ··································································· 11
나. 요양병원 입원급여 적정성 평가 ·································································· 20
다. 국가 항생제 내성 관리대책 ········································································ 25
2. 국외 ···································································································· 29
가. 미국 ········································································································ 29
나. 호주 ········································································································ 37
다. 일본 ········································································································ 45
3. 소결 ···································································································· 50
제3장 항생제 사용 관련 청구자료 분석
1. 자료 분석 개요 ···················································································· 53
가. 자료원 및 분석 대상 ················································································· 53
나. 분석 내용 ································································································ 53
2. 요양병원 항생제 사용 현황 ···································································· 63
가. 전체 항생제 사용 분석 ·············································································· 63
나. 지표 개발을 위한 항생제 사용 분석 ··························································· 76
3. 요양병원 항생제 사용 관련 요인 ·························································· 112
가. 미생물 검사 현황 ···················································································· 112
나. 요양병원과 급성기 병원 간 환자 이동 ······················································· 117
4. 소결 ·································································································· 118
제4장 요양병원 항생제 사용 표준화 모형 개발
1. 자료 분석 개요 ·················································································· 123
가. 자료원 ··································································································· 123
나. 분석 내용 ······························································································ 124
2. 항생제 사용에 영향을 미치는 요인 탐색 ··············································· 129
가. 요양병원 중증도 보정 변수 선정 ······························································ 129
나. 요양병원의 항생제 사용 분포 ··································································· 129
다. 항생제 사용과 보정 변수 간 상관관계 ······················································· 133
3. 요양병원 항생제 사용 표준화 모형 개발 ··············································· 147
가. 항생제 사용 표준화 모형 ········································································· 147
나. 모형 타당도 검증 및 최종 모형 선택 ························································ 148
4. 요양병원 표준화 항생제 사용비(SAAR) 비교 ········································· 170
가. 환자단위 모형에서 표준화 항생제 사용비 ·················································· 170
나. 청구단위 모형에서 표준화 항생제 사용비 ·················································· 177
다. 항생제 사용 그룹 비교 ············································································ 184
5. 소결 ·································································································· 190
제5장 요양병원 관계자 의견 조사
1.요양병원 항생제 사용 및 관리 관련 관계자 의견 조사 ····························· 197
가. 개요 ······································································································ 197
나. 의견 조사 결과 ······················································································· 199
2. 소결 ·································································································· 207
제6장 결론 및 제언
1. 결론 ·································································································· 213
2. 향후 제언 ·························································································· 220
3. 연구의 한계 및 의의 ··········································································· 223
◾ 참고 문헌 ····················································································· 225
◾ 부록 ····························································································· 229
◾ ABSTRACT ················································································· 265
- Publisher
- 건강보험심사평가원
- Location
- KOR
- Citation
- 채정미. (2025-01). 요양병원의 항생제 현황 분석 및 평가지표 개발.
- 파일 목록
-
-
Download
요양병원의 항생제 현황 분석 및 평가지표 개발.pdf
기타 데이터 / 7.46 MB / Adobe PDF
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.